No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs73023273 |
chr1:162086785-162086786 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs531240457 |
chr1:162086854-162086855 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs191468569 |
chr1:162086880-162086881 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs531353826 |
chr1:162086889-162086890 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs568210607 |
chr1:162086970-162086971 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs151115055 |
chr1:162087008-162087009 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs139922010 |
chr1:162087063-162087064 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs149813469 |
chr1:162087070-162087071 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs556606949 |
chr1:162087093-162087094 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs576369706 |
chr1:162087122-162087123 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs547912353 |
chr1:162087141-162087142 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs541867508 |
chr1:162087146-162087147 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs555394969 |
chr1:162087152-162087153 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs369141527 |
chr1:162087186-162087187 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs145525782 |
chr1:162087226-162087227 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs181645915 |
chr1:162087230-162087231 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs532232622 |
chr1:162087243-162087244 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs534948095 |
chr1:162087244-162087245 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs546061058 |
chr1:162087245-162087246 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs140271336 |
chr1:162087251-162087252 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs147421409 |
chr1:162087354-162087355 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs185539333 |
chr1:162087381-162087382 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs548213627 |
chr1:162087406-162087407 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs190249425 |
chr1:162087409-162087410 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs533690286 |
chr1:162087456-162087457 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs10800312 |
chr1:162087493-162087494 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
27 |
rs80069991 |
chr1:162087541-162087542 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs200144605 |
chr1:162087581-162087582 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs571003664 |
chr1:162087596-162087597 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs182833449 |
chr1:162087676-162087677 |
Weak transcription Enhancers ZNF genes & repeats Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs570721710 |
chr1:162087679-162087680 |
Weak transcription Enhancers ZNF genes & repeats Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs187558454 |
chr1:162087705-162087706 |
Weak transcription Enhancers ZNF genes & repeats Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs570255256 |
chr1:162087746-162087747 |
Weak transcription Enhancers ZNF genes & repeats Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs113144039 |
chr1:162087772-162087773 |
Weak transcription Enhancers ZNF genes & repeats Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs535416763 |
chr1:162087797-162087798 |
Weak transcription Enhancers ZNF genes & repeats Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs539599271 |
chr1:162087798-162087799 |
Weak transcription Enhancers ZNF genes & repeats Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs572177504 |
chr1:162087850-162087851 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs541103745 |
chr1:162087882-162087883 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs558002733 |
chr1:162087976-162087977 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs556452456 |
chr1:162087977-162087978 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs80349199 |
chr1:162088034-162088035 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs562758975 |
chr1:162088063-162088064 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs531650896 |
chr1:162088078-162088079 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs541815051 |
chr1:162088106-162088107 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs561690967 |
chr1:162088134-162088135 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs191153899 |
chr1:162088192-162088193 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs367980767 |
chr1:162088203-162088204 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs118077420 |
chr1:162088211-162088212 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs564066901 |
chr1:162088215-162088216 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs536122214 |
chr1:162088216-162088217 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|